Treatment

Oncogenic LGR5-mediated Wnt signalling as a target for neuroblastoma therapy

Enhancing immunity against neuroblastoma through the exploitation of antigen-specific T cell co-stimulation receptors

Molecularly Guided Treatment in Childhood Cancer

Identification of MSH6 null individuals in patients suspected of suffering from Constitutional Mismatch Repair Cancer Syndrome

Development of GD2-specific Bi-specific T-cell Engagers (BiTEs) for treatment of neuroblastoma

Pre-clinical drug validation in acute lymphoid and myeloid leukaemia